<DOC>
	<DOCNO>NCT00174460</DOCNO>
	<brief_summary>Safety efficacy Somatropin evaluate short child born list weight 1500 g catch normal height age 4 .</brief_summary>
	<brief_title>Somatropin Therapy In Children Born Preterm But Appropriate For Gestational Age</brief_title>
	<detailed_description />
	<mesh_term>Birth Weight</mesh_term>
	<criteria>Subjects must meet follow inclusion criterion eligible enrollment trial : Prepubertal caucasian boys 4 10 year age girls 4 9 year age . Girls : Tanner stage 1 breast development Boys : Testis volume &lt; = 3ml Tanner stage 1 pubic hair development ( exclude confound effect adrenarche growth velocity , insulin sensitivity body composition ) . ( In case sign symptom gonadal puberty GnRHTest must decide subject still pubertal . ) Height &lt; =2 SD chronological age ( Brandt/Reinken ) . Growth velocity SDS 0 SD chronological age ( Brandt/Reinken base 12+/ 3 month observation period screen ) . Premature bear define &lt; =1500 g birth weight . GH sufficiency ( GH level &gt; 7 ug/l follow routine GH stimulation test ) . Written inform consent parent ( legal guardian ) oral/written consent subject due age specific information . Subjects present follow included trial : Other endocrine disease except well substitute hypothyroidism . Severe chronic disease medication might influence linear growth insulin sensitivity ( e.g . Glucocorticoids ) . Positive GAD IA2 antibody ( type 1 diabetes ) . History malignancy Children meet follow 4 criterion : actual body height &lt; 2,5 SDS ( Brandt/Reinken ) parent adjust target height &lt; 1 SDS ( Hermanussen Cole , 2003 ) length and/or body weight retardation adjust gestational age birth &lt; 2,0 SDS ( Lawrence et al. , 1989 , Voigt et al. , 1996 ) child chronological age &gt; = 4 year growth velocity &lt; 0 SDS last year inclusion . Chromosomal aberration syndrome . Suspected noncompliance impossibility follow two three year treatment schedule , respectively ( e.g . social implication ) . Severe hemiparesis severe CNS defect Retinopathia &gt; third degree laser treatment newborn . Participation clinical trial active treatment phase . Other severe acute chronic medical psychiatric condition clinically relevant laboratory abnormality may increase risk associate trial participation investigational product administration may interfere interpretation trial result , judgement investigator , would make subject inappropriate entry trial .</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>